Retina Synthesis

147 Folgen

1. Biosimilar Drugs for Retinal Diseases

   Vom: 6.7.2023
2. Faricimab vs Aflibercept in Diabetic Macular Edema

   Vom: 29.6.2023
3. Artificial Intelligence in the Management of Geographic Atrophy

   Vom: 22.6.2023
4. Molecular Diagnostics in the Diagnosis and Treatment of Uveal Melanoma

   Vom: 15.6.2023
5. Faricimab in the Treatment of Retinal Venous Occlusion

   Vom: 8.6.2023
6. The Use of High Dose Aflibercept in Diabetic Macular Edema

   Vom: 1.6.2023
7. Widefield OCT Angiography

   Vom: 25.5.2023
8. Aflibercept Therapy of Retinopathy of Prematurity

   Vom: 18.5.2023
9. Home OCT in the Management of Neovascular AMD: Latest Development

   Vom: 11.5.2023
10. Suprachoroidal Corticosteroids for the Treatment of Macular Edema

    Vom: 4.5.2023
11. The Use of the Port Delivery System for the Treatment of Diabetic Macular Edema

    Vom: 27.4.2023
12. Suprachoroidal Therapy of Neovascular AMD

    Vom: 20.4.2023
13. Microperimetry in the Assessment of Geographic Macular Atrophy

    Vom: 13.4.2023
14. Subretinal Gene Therapy for Neovascular AMD

    Vom: 6.4.2023
15. A Tyrosine Kinase Inhibitor Implant for the Treatment of Neovascular AMD

    Vom: 30.3.2023
16. 15 Year Results of Fixed Dose Anti-VEGF Treatment of Neovascular AMD

    Vom: 23.3.2023
17. Dexamethasone Implant for Treating Diabetic Macular Edema

    Vom: 16.3.2023
18. Retinal Vasculitis Update

    Vom: 2.3.2023
19. Central Serous Chorioretinopathy

    Vom: 23.2.2023
20. Faricimab Update

    Vom: 16.2.2023